All lobbying filings

CENTENE CORPORATION

CENTENE CORPORATION filed a Q2 report for CENTENE CORPORATION on July 20, 2026.

Lobbying for CENTENE CORPORATION

All filings by CENTENE CORPORATION · Everything CENTENE CORPORATION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$1,460,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

S. 2355, Patients Deserve Price Tags Act, including provisions related to the hold-harmless of insurers. Issues related to health insurance access and affordability. Issues related to the individual insurance market.

Medicare/Medicaid

H.R. 5454, Medicare Advantage Prompt Pay Act, including provisions related to medical claims payment requirements for Medicare Advantage organizations. H.R. 9393, Lower Costs, More Transparency Act of 2026, including provisions related to the current Transparency in Coverage requirements. Issues related to healthcare quality (Medicare Advantage) and MA Stars policy reform. Issues related to Medicare Advantage supplemental benefits, specifically impact of access to healthy foods on health outcomes.

Bills named in this filing 3

S. 2355
Patients Deserve Price Tags Act
H.R. 5454
Medicare Advantage Prompt Pay Act
H.R. 9393
Lower Costs, More Transparency Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.